XML 38 R26.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Share-based Compensation
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Share-based Compensation

20.

Share-based Compensation 


On October 26, 2016, the Company’s Board of Directors approved the issuance of up to 25,000 shares of the Company’s common stock (1,250 shares as adjusted for the May Stock Split), in the form of restricted stock or options (“2016 Stock Plan”). Effective January 20, 2017, the 2016 Stock Plan was amended and restated as the SG Blocks, Inc. Stock Incentive Plan, as further amended effective June 1, 2018 and as further amended on July 30, 2020 and as further amended on August 18, 2021, (the “Incentive Plan”). The Incentive Plan authorizes the issuance of up to 3,625,000 shares of common stock (181,250 shares as adjusted for the May Stock Split),. It authorizes the issuance of equity-based awards in the form of stock options, stock appreciation rights, restricted shares, restricted share units, other share-based awards and cash-based awards to non-employee directors and to officers, employees and consultants of the Company and its subsidiary, except that incentive stock options may only be granted to the Company’s employees and its subsidiary’s employees. The Incentive Plan expires on October 26, 2026, and is administered by the Company’s Compensation Committee of the Board of Directors. Each of the Company’s employees, directors, and consultants are eligible to participate in the Incentive Plan. As of December 31, 2023, there were 0 shares of common stock available for issuance under the Incentive Plan.


Stock-based compensation expense is included in the consolidated statements of operations as follows:





Year Ended December 31,



2023
2022

Payroll and related expenses

   

$

3,210,631

   

   

$

2,798,844

   


General and administrative expenses






       Total

   

$

3,210,631

   

 

$

2,798,844

   

 

The following table presents total stock-based compensation expense by security type included in the consolidated statements of operations:





 Year Ended December 31,




 2023

2022


Stock options


$

  

  

$

   


RSUs 

 

 

3,210,631

  

  

 

2,798,844

   


Total
$ 3,210,631

$ 2,798,844


Because the Company does not have significant historical data on employee exercise behavior, the Company uses the “Simplified Method” to calculate the expected life of the stock-based option awards granted to employees. The simplified method is calculated by averaging the vesting period and contractual term of the options.

The following table summarizes stock-based option activities and changes during the years ended December 31, 2023 and 2022, as described below: 

 


 

 

 Shares

 

 

Weighted Average Fair Value Per Share

 

 

Weighted
Average Exercise Price Per Share

 

 

Weighted Average Remaining Terms (in years)

 

 

Aggregate Intrinsic Value

 


Outstanding – December 31, 2021

1,822

$ 496.00

$ 1,574.20


5.34

$

Granted

















Exercised
















Cancelled
















Outstanding – December 31, 2022

 

 

1,822

 

 

$

496.00

 

 

$

1,574.20

 

 

 

4.34

 

 

$

 


Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Cancelled

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 


Outstanding – December 31, 2023

 

 

1,822

 

 

 

496.00

 

 

 

1,574.20

 

 

 

 

 

$

 


Exercisable – December 31, 2022

 

 

1,822

 

 

 

496.00

 

 

 

1,574.20

 

 

 

4.34

 

 

 

 


Exercisable – December 31, 2023

 

 

1,822

 

 

$

 

 

$

 

 

 

 

 

$

 

  

For the years ended December 31, 2023 and December 31, 2022, the Company recognized stock-based compensation expense of $0 and $0, respectively, related to stock options. This expense is included in payroll and related expenses in the accompanying consolidated statements of operations.

 

As of December 31, 2023, there was no unrecognized compensation costs related to non-vested stock options and all options have been expensed. The intrinsic value is calculated as the difference between the fair value of the stock price at year end and the exercise price of each of the outstanding stock options. The fair value of the stock price at December 31, 2023 was $0.0 per share.


Restricted Stock Units


During 2022, a total of 1,045,000 (52,250 as adjusted for the May Stock Split) of restricted stock units were granted to Mr. Galvin and seven employees of the Company, under the Company’s stock-based compensation plan, at the fair value ranging from $1.30 to $2.24 per share ($26 to $44.80 adjusted for the May Stock Split), which represents the closing price of the Company’s common stock at the date of grant. The restricted stock units granted vest quarterly over two years from the anniversary of the grant date. The fair value of these units upon issuance amounted to $1,843,000.


On November 18, 2022, a total of 80,000 of restricted stock units (4,000 as adjusted for the May Stock Split) were granted to four of the Company's non-employee directors, under the Company's stock-based compensation plan, at the fair value of $1.30 per share ($26.00 adjusted for the May Stock Split), which represents the closing price of the Company's common stock on November 18, 2022. The restricted stock units granted vest in equal quarterly installments over a two-year period.


During the three months ended June 30, 2023, a total of 316,834 of restricted stock units (15,842 as adjusted for the May Stock Split) were granted to Mr. Galvin and six employees of the Company under the Company's stock-based compensation plan, at the fair value of $0.85 to $1.01 per share ($17 to $20.20 as adjusted for the May Stock Split), which represents the closing price of the Company's common stock at the grant date. The restricted stock units granted vest in equal quarterly installments over a two-year period.


On April 4, 2023, a total of 268,166 of restricted stock units (13,408 as adjusted for the May Stock Split) were granted to five of the Company's non-employee directors, under the Company's stock-based compensation plan, at the fair value of $1.01 ($20.20 as adjusted for the May Stock Split) per share, which represents the closing price of the Company's common stock on April 4, 2023. The restricted stock units granted vest in equal quarterly installments over a two-year period


For the year ended December 31, 2023 and 2022, the Company recognized stock-based compensation of $3,210,631 and $2,798,844 related to restricted stock units. This expense is included in the payroll and related expenses and general and administrative expenses in the accompanying consolidated statement of operations. As of December 31, 2023, there was a total of $0 in unrecognized compensation costs related to non-vested restricted stock units. 


The following table summarized restricted stock unit activities during the year ended December 31, 2023:  




    Number of Shares


Non - vested balance at January 1, 2023



59,547


Granted



29,250

Vested
(88,797 )

Forfeited/Expired

Non - vested balance at December 31, 2023